Wikidata

(Q61868247)

English

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

scientific article published in January 2000

In more languages

Statements

title
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma (English)
0 references
author name string
J M Foran
series ordinal
1
0 references
A Z Rohatiner
series ordinal
2
0 references
R A Popescu
series ordinal
4
0 references
P Solal-Celigny
series ordinal
5
0 references
M Ghielmini
series ordinal
6
0 references
B Coiffier
series ordinal
7
0 references
P W Johnson
series ordinal
8
0 references
C Gisselbrecht
series ordinal
9
0 references
F Reyes
series ordinal
10
0 references
J A Radford
series ordinal
11
0 references
E M Bessell
series ordinal
12
0 references
B Souleau
series ordinal
13
0 references
A Benzohra
series ordinal
14
0 references
T A Lister
series ordinal
15
0 references
publication date
January 2000
0 references
volume
18
0 references
page(s)
317-24
0 references
issue
2
0 references

Identifiers

PubMed ID
10637245
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61868247&oldid=2116193450"